Ranibizumab 68225-0123
Product NDC
68225-0123- Manufacturer
- Patheon Italia S.p.a.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- June 1, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranibizumab | 10 mg/mL |
Packaging Options(1)
1800 VIAL, SINGLE-DOSE in 1 BOX (68225-123-00) / .05 mL in 1 VIAL, SINGLE-DOSE